Knockout of 5-lipoxygenase results in age-dependent anxiety-like behavior in female mice

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Joshi, Yash B ^a   Praticò, Domenico ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE;

ADOLESCENT; ADULTHOOD; AGE; ANIMAL EXPERIMENT; ANXIETY; ANXIETY LIKE BEHAVIOR; ARTICLE; CONTROLLED STUDY; FEMALE; KNOCKOUT MOUSE; MAZE TEST; MOUSE; NONHUMAN; PHENOTYPE; WILD TYPE; AGING; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; ENZYMOLOGY; METABOLISM; MOUSE MUTANT; PATHOLOGY;

ANIMALIA; MUS;

AGING; ANIMALS; ANXIETY; ARACHIDONATE 5-LIPOXYGENASE; BEHAVIOR, ANIMAL; FEMALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 84855296484     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029448     Document Type: Article

References (22)

1. Duroudier NP, Tulah AS, Sayers I, (2009) Leukotriene pathway genetics and pharmacogenetics in allergy. Allergy 64: 823-839.
2. Feuerstein G, Hallenbeck JM, (1987) Leukotrienes in health and disease. FASEB 1: 186-192.
3. Samuelsson B, Dahlen SE, Lindgren JA, Rouzer, CA, Serhan CN, (1987) Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237: 1171-1176.
4. Chu J, Pratico D, (2011) Pharmacologic blockade of 5-lipoxygenase improves the amyloidotic phenotype of an Alzeheimer's disease transgenic mouse model involvement of gamma-secretase. Am J Path 178: 1762-1769.
5. Stewart LR, White AR, Jobling MF, Needham BE, Maher F, et al. (2001) Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion protein peptide PrP106-126. J Neurosc Res 65: 565-572.
6. Whitney LW, Ludwin SK, McFarland HF, Biddison WE, (2001) Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions. J Neuroimmunol 121: 40-48.
7. Uz T, Dwivedi Y, Pandey GN, Roberts RC, Conley RR, et al. (2008) 5-lipoxygenase in the prefrontal cortex of suicide victims. Neuropsychopharmacology 1: 1-5.
8. Uz T, Dimitrijevic N, Imbesi M, Manev H, Manev R, (2008) Effect of MK-866, a 5-lipoxygenase activating protein (FLAP) inhibitor, and 5-lipoxygenase deficiency on the forced swimming behavior of mice. Neurosci Lett 436: 269-272.
9. Uz T, Dimitrijevic N, Tueting P, Manev H, (2002) 5-lipoxygenase (5LOX)-deficient mice express reduced anxiety-like behavior. Restor Neurol and Neurosci 20: 15-20.
10. Kessler RC, Amminger GP, Aguilar-Gaxiola S, Alsono J, Lee S, et al. (2007) Age of onset of mental disorders: a review of recent literature. Curr Opin Psychiatry 20: 359-364.
11. Chinnici CM, Yao, Y, Pratico, D, (2007) The 5-lipoxygenase enzymatic pathway in the mouse brain: young versus old. Neurobiol Aging 28: 1457-1462.
12. Puccio S, Chu J, Pratico D, (2011) Involvement of 5-lipoxygenase in the corticosteroid-dependent amyloid beta formation: in vitro and in vivo evidence. PLoS One 6: e151563.
13. Manev R, Manev H, (2004) 5-lipoxygenase as a putative link between cardiovascular and psychiatric disorders. Crit Rev Neurobiol 16: 181-186.
14. Pellow S, Chopin P, File SE, Briley M, (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14: 149-167.
15. Walf AA, Frye CA, (2007) The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2: 322-328.
16. Fahlstrom A, Yu Q, Ulfhake B, (2011) Behavioral changes in aging female C57BL/6 mice. Neurobiol Aging 32: 1868-1880.
17. Kurtuncu M, Battista N, Uz T, D'Agostino A, Dimitrijevic N, et al. (2008) Effects of cocaine in 5-lipoxygenase-deficient mice. J Neural Transm 115: 389-95.
18. Pergola C, Dodt G, Rossi A, Neunhoeffer E, Lawrenz B, et al. (2008) ERK-mediated regulation of leukotriene biosynthesis by androgens: a molecular basis for gender differences in inflammation and asthma. Proc Natl Acad Sci U S A 105: 19881-19886.
19. Pergola C, Rogge A, Dodt G, Northoff H, Weinigel C, et al. (2011) Testosterone suppresses phospholipase D, causing sex differences in leukotriene biosynthesis in human monocytes. FASEB 10: 3377-3387.
20. Johnston NW, Mandhane JD, Duncan JM, Greene JM, Lambert K, et al. (2007) Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy. Pediatrics 120: e702-712.
21. Klotsman M, York TP, Pillai SG, Vargas-Irwin C, Sharma SS, et al. (2007) Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukast. Pharmacogenet and Genomics 17: 189-96.
22. Zhao J, Quyyumi AA, Patel R, Zafari AM, Veledar E, et al. (2009) Sex-specific association of depression and a haplotype in leukotriene A4 hydrolase gene. Psychosom Med 71: 691-6.